Response to Letters Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery"

Affiliations

¹ National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
² Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
³ National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
⁴ School of Public Health, Capital Medical University, Beijing, People's Republic of China.

Comment

Zhe Zheng et al. Circulation. 2016.

. 2016 Feb 9;133(6):e394-5.

doi: 10.1161/CIRCULATIONAHA.115.019468.

¹ National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
² Department of Cardiovascular Surgery, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
³ National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
⁴ School of Public Health, Capital Medical University, Beijing, People's Republic of China.

No abstract available

Comment on

Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery.
Zhang H, Yuan X, Zhang H, Chen S, Zhao Y, Hua K, Rao C, Wang W, Sun H, Hu S, Zheng Z. Zhang H, et al. Circulation. 2015 Jun 23;131(25):2194-201. doi: 10.1161/CIRCULATIONAHA.114.014209. Epub 2015 Apr 23. Circulation. 2015. PMID: 25908770 Free PMC article.
Letter by Poullis Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".
Poullis M. Poullis M. Circulation. 2016 Feb 9;133(6):e391. doi: 10.1161/CIRCULATIONAHA.115.018190. Circulation. 2016. PMID: 26858297 No abstract available.
Letter by Bergerot et al Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".
Bergerot C, Farhat F, Mewton N. Bergerot C, et al. Circulation. 2016 Feb 9;133(6):e392. doi: 10.1161/CIRCULATIONAHA.115.018316. Circulation. 2016. PMID: 26858298 No abstract available.
Letter by Kardesoglu et al Regarding Article, "Efficacy of Long-Term β-Blocker Therapy for Secondary Prevention of Long-Term Outcomes After Coronary Artery Bypass Grafting Surgery".
Kardesoglu E, Isilak Z, Yalcin M. Kardesoglu E, et al. Circulation. 2016 Feb 9;133(6):e393. doi: 10.1161/CIRCULATIONAHA.115.018675. Circulation. 2016. PMID: 26858299 No abstract available.